New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - olanzapine 10mg - orodispersible tablet - 10 mg - active: olanzapine 10mg excipient: aspartame colloidal silicon dioxide crospovidone avicel ce 15 (microcrystalline cellulose 85% and guar gum 15%) magnesium stearate mannitol microcrystalline cellulose pregelatinised maize starch sodium laurilsulfate - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses.

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - olanzapine 5mg - orodispersible tablet - 5 mg - active: olanzapine 5mg excipient: aspartame colloidal silicon dioxide crospovidone avicel ce 15 (microcrystalline cellulose 85% and guar gum 15%) magnesium stearate mannitol microcrystalline cellulose pregelatinised maize starch sodium laurilsulfate - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses.

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - olanzapine 10mg; olanzapine 10mg - film coated tablet - 10 mg - active: olanzapine 10mg excipient: crospovidone hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry blue 06b50833 active: olanzapine 10mg excipient: crospovidone hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry white 06b580002 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses.

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - olanzapine 2.5mg - film coated tablet - 2.5 mg - active: olanzapine 2.5mg excipient: crospovidone hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry white oy-58900 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses.

New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's new zealand limited - olanzapine 5mg; olanzapine 5mg - film coated tablet - 5 mg - active: olanzapine 5mg excipient: crospovidone hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry blue 06b50833 active: olanzapine 5mg excipient: crospovidone hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry white 06b580002 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olanzapine, quantity: 15 mg - tablet, film coated - excipient ingredients: hypromellose; microcrystalline cellulose; magnesium stearate; lactose monohydrate; hyprolose; crospovidone; titanium dioxide; polysorbate 80; macrogol 400; indigo carmine aluminium lake - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses.,olanzapine tablets alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.,olanzapine tablets are also indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olanzapine, quantity: 5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; hypromellose; lactose monohydrate; hyprolose; titanium dioxide; polysorbate 80; macrogol 400 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses. ,olanzapine tablets alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine tablets are also indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olanzapine, quantity: 15 mg - tablet, film coated - excipient ingredients: hyprolose; crospovidone; magnesium stearate; microcrystalline cellulose; lactose monohydrate; hypromellose; titanium dioxide; polysorbate 80; macrogol 400; indigo carmine aluminium lake - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses. ,olanzapine tablets alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine tablets are also indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - olanzapine, quantity: 10 mg - tablet, film coated - excipient ingredients: hypromellose; crospovidone; microcrystalline cellulose; lactose monohydrate; magnesium stearate; hyprolose; titanium dioxide; polysorbate 80; macrogol 400 - olanzapine tablets are indicated for the treatment of schizophrenia and related psychoses. ,olanzapine tablets alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,olanzapine tablets are also indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Israel - English - Ministry of Health

abic marketing ltd, israel - olanzapine - film coated tablets - olanzapine 5 mg - olanzapine - acute and maintenance treatment of schizophrenia. olanzapine teva® is indicated for the management of the manifestations of psychotic disorders. olanzapine teva® is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.prevention of recurrence in bipolar disorder: in patients whose manic episode has responded to olanzapine treatment olanzapine teva® is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder. the combination of olanzapine teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.